AI-Driven Denials: 61% of Physicians Fear Insurer Automation

February 23, 2025

·

8 min

The Escalating Crisis: AI-Enabled Denial Systems in Healthcare

The integration of artificial intelligence into health insurance operations has precipitated a critical inflection point in American healthcare delivery. According to a comprehensive American Medical Association survey, 61% of physicians express concern that insurers will leverage AI technology to increase denials of pre-approval for treatment Most doctors fear insurers using AI to deny coverage, marking a watershed moment in the ongoing tension between clinical autonomy and administrative gatekeeping.

Dr. Bruce A. Scott, president of the American Medical Association, articulated the medical community's apprehension in unequivocal terms:

"Using AI-enabled tools to automatically deny more and more needed care is not the reform of prior authorization physicians and patients are calling for."

The Systematic Deployment of Automated Denial Systems

The concern extends beyond theoretical risk to documented operational reality. Scott emphasized the scope of the problem:

"Emerging evidence shows that insurers use automated decision-making systems to create systematic batch denials with little or no human review, placing barriers between patients and necessary medical care."

This revelation underscores a fundamental transformation in how coverage determinations are executed—shifting from individualized clinical review to algorithmic processing at scale. The implications for clinical practice are profound and measurable. While insurers defend prior authorization as essential for cost control and preventing medically unnecessary procedures, the physician experience reveals a more troubling pattern of systematic obstruction rather than thoughtful utilization management.

Quantifying the Clinical and Human Cost

The AMA survey data illuminates the tangible consequences of prior authorization friction on patient care delivery:

Care Delays and Treatment Abandonment

An overwhelming 93% of physicians report that prior authorization delays patient care at minimum, while 82% indicate that patients have abandoned treatment due to delays in prior authorization in at least some cases Most doctors fear insurers using AI to deny coverage. This represents not merely administrative inconvenience but a fundamental barrier to evidence-based care delivery.

Adverse Clinical Outcomes

The survey reveals disturbing patterns of patient harm directly attributable to authorization delays. Nearly 29% of physicians report that roadblocks in prior authorization have led to serious adverse events, while 23% indicated delays in approval resulted in patients requiring hospitalization Most doctors fear insurers using AI to deny coverage. These statistics document iatrogenic harm resulting from administrative rather than clinical decisions.

Physician Workforce Impact

The vast majority of physicians—89%—reported that prior authorization battles contribute significantly to physician burnout Most doctors fear insurers using AI to deny coverage, exacerbating an already critical workforce crisis. The operational burden is substantial: 40% of physicians maintain staff whose sole function is managing prior authorization Most doctors fear insurers using AI to deny coverage, representing significant opportunity cost and inefficiency.

Gary Price, president of The Physicians' Foundation, characterized the evolution succinctly:

"It's become a full-fledged obstacle course that frustrates physicians. It delays patient care. It can even prevent good patient care. It lowers the quality of that care."

The Arms Race: Technology Versus Technology

A particularly concerning dynamic has emerged in the claims and authorization ecosystem. Ash Shehata, KPMG's U.S. sector leader for healthcare, observed that as health systems improve their ability to submit claims, "the payers are also improving their ability to extract the information and deny claims. So we're not really gaining ground here together."

This technological arms race produces no net improvement in efficiency or patient care. Instead, it escalates administrative costs and complexity while maintaining—or worsening—the fundamental barriers to care access.

In a September 2024 hospital association report, healthcare organizations documented that AI tools deployed by insurers lead to wrongful claim denials Most doctors fear insurers using AI to deny coverage, noting:

"Poor applications of these technologies can result in automatic denials of care without consideration of a patient's individual clinical circumstances or review from a clinician or plan medical director as required."

The Paradox: Physicians Embrace AI While Fearing Its Misuse

The physician perspective on AI is notably nuanced. A separate AMA survey revealed that two out of three doctors currently use AI in their practice in some capacity, representing a dramatic increase from 38% in 2023 Most doctors fear insurers using AI to deny coverage. This demonstrates that physician concerns center not on AI technology itself but on its application in claims denial systems.

The distinction is critical: physicians recognize AI's potential to enhance diagnostic accuracy, streamline documentation, and support clinical decision-making. The anxiety emerges specifically when AI systems are deployed to systematically override physician judgment regarding medical necessity.

The Call for Regulatory Oversight

Nearly half of all physicians—49%—advocate for increased regulatory scrutiny of how payers utilize AI in treatment approval processes Most doctors fear insurers using AI to deny coverage. This represents a clear mandate for policy intervention to ensure that algorithmic systems enhance rather than obstruct appropriate care delivery.

Dr. Scott emphasized this imperative with clarity:

"Medical decisions must be made by physicians and their patients without interference from unregulated and unsupervised AI technology."

Implications for Medical Practice

For private practice physicians and healthcare administrators, these findings necessitate strategic adaptation:

  1. Documentation Enhancement: Anticipating algorithmic review requires meticulous, structured documentation that explicitly addresses medical necessity criteria.
  2. Advocacy Preparation: Practices should develop systematic processes for appeals and peer-to-peer reviews, recognizing that initial denials may increasingly reflect algorithmic rather than clinical judgment.
  3. Resource Allocation: The reality that 40% of practices employ dedicated authorization staff suggests this function requires professional investment rather than ad hoc management.
  4. Policy Engagement: Physician involvement in regulatory discussions and professional society advocacy becomes essential to ensure appropriate oversight of AI-enabled denial systems.

Conclusion: Reclaiming Clinical Autonomy in the Algorithm Age

The deployment of AI in health insurance operations represents a critical juncture requiring deliberate policy choices. The technology itself is neutral; its application reflects organizational priorities and regulatory frameworks. The current trajectory—toward systematic, minimally supervised algorithmic denials—threatens both patient welfare and physician sustainability.

The medical community's response must combine immediate operational adaptation with sustained advocacy for regulatory frameworks ensuring that AI systems augment rather than supplant clinical judgment. The stakes extend beyond administrative efficiency to encompass the fundamental question of whether medical necessity determinations remain primarily clinical or become primarily actuarial functions masked by algorithmic opacity.

Related Posts

Blog Post Image

March 25, 2026

·

6 min

When AI Alerts Override Clinical Judgment, Who's Liable?

AI-driven sepsis flags, wearable monitors generating false positives, and agentic systems replacing nurse calls—clinical AI is accelerating without sufficient validation.

Blog Post Image

March 20, 2026

·

6 min

Performance Drives Patient Trust More Than Governance

A national survey of 3,000 U.S. adults reveals that AI performance — not FDA approval or physician oversight — is the single strongest driver of patient trust in medical AI. AI performing at specialist level increased visit selection by 32.5%, a finding with direct implications for how practices deploy and communicate AI tools.

Blog Post Image

March 10, 2026

·

5 min

AI Health Tools Are Here—But Are They Clinically Ready?

ChatGPT Health launched in January 2026—but a new study reveals it failed to properly triage the most and least serious cases.

Blog Post Image

March 4, 2026

·

7 min

Food Is Medicine: The $1.1T Case for Clinical Action Now

Poor diet drives CVD, type 2 diabetes, and stroke—costing $1.1 trillion annually in the US alone. A landmark JAMA Health Forum special communication argues that physicians now have the policy tools, EHR infrastructure, and clinical workflows to make "Food is Medicine" a standard of care—if they choose to act.

Blog Post Image

February 24, 2026

·

6 min

AI Scribes Capture More Symptoms—But Treat Fewer Patients

AI ambient scribes produce richer psychiatric documentation across all 6 neuropsychiatric domains—yet AI-scribed visits were 17% less likely to result in a depression diagnosis, new prescription, or behavioral health referral. Documentation and action are diverging.

Blog Post Image

February 11, 2026

·

4 min

Telehealth Cuts Both Good and Bad Tests—What Physicians Must Know

A landmark JAMA Network Open study of 22,547 propensity-matched annual visits reveals that virtual visits reduce high-value test ordering by 14.3% and low-value test ordering by 19.3% compared with in-person visits. Telehealth's promise as a care-quality lever is more complicated—and more consequential—than previously understood.